Monitor and regulation of T-cell immune reconstitution post hematopoietic stem cell transplantation

( views:139, downloads:0 )
LI Yang-qiu(Institute of Hematology, Medical College, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou 510632, China)
Journal Title:
Journal of Leukemia & Lymphoma
Volume 21, Issue 02, 2012
Key Word:
Hematopoietic stem cell transplantation;T -cell;Immune reconstitution;American Society of Hematology annual meeting

Abstract: T-cell immune reconstitution after hematopoietic stem cell transplantation (HSCT) is important for prevention of virus infections and disease relapse. How to modify the conditioning regimen and the graft composition to promote immune recovery post HSCT was one of the key issue of transplant immunology from 2011 ASH annual meeting.In this review,advance knowledge concerning the T-cell immune reconstitution post HSCT is summarized.

  • [1]Krell PFI,Weber S,Reuther S,et al. Next generation sequencing spectratyping (NGS-S) comprehensively monitors T cell receptor diversity in children with T cell abnormalities. 2011 ASH Meeting:Abstract 2173.
  • [2]Brown J,Kim HT,Cutler C,et al.Immune reconstitution after cord blood transplantation in adults depends on activity of thymic epithelial cells and vascular endothelial elements.2011 ASH Meeting:Abstract 4075.
  • [3]Kanda J, Rizzieri DA, Long GD, et al. The impact of lymphocyte subset recovery at 3 months on progression-free survival after myeloablative allogeneic stem cell transplantation.2011 ASH Meeting:Abstract 4065.
  • [4]Jimenez-Zepeda VH,Reece DE,Trudel S,et al.Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant:experience of a single centre.2011 ASH Meeting:Abstract 4121.
  • [5]McGoldrick SM,Guerrero A,Yamamoto TN,et al.Cytomegalovirusspecific T cells are elicited early after umbilical cord blood transplant but fail to expand in vivo and control virus replication. 2011 ASH Meeting:Abstract 1974.
  • [6]Kalina T,Krol L,Stuchly J,et al.Dual production of IL-2 and IFN-gamma by CMV-specific CD8+ T-cells is a hallmark of their ability to control CMV reactivation in patients after hematopoietic stem cell transplantation.2011 ASH Meeting:Abstract 4081.
  • [7]李扬秋.异基因免疫治疗促进移植物抗肿瘤效应的探讨.白血病·淋巴瘤,2011,20:3-5,12.
  • [8]Bosch M,Dhadda M,Hoegh-Petersen M,et al.Immune reconstitution after antithymocyte globulin (ATG)-conditioned hematopoietic cell transplantation (HCT).2011 ASH Meeting:Abstract 1981.
  • [9]Handgretinger R,Lang P,Feuchtinger TF,et al.Transplantation of TcR α β/CD19 depleted stem cells from haploidentical donors:robust engraftment and rapid immune reconstitution in children with high risk leukemia.2011 ASH Meeting,Abstract 1005.
  • [10]Waller EK,Harris WAC,Devine S,et al.Larger numbers of donor naive CD 8+ T-cells and plasmacytoid dendritic cell precursors in allogeneic BM grafts from unrelated donors are associated with improved survival:results from BMT CTN 0201.2011 ASH Meeting:Abstract 1004.
  • [11]Perruccio K,Ruggeri L,Moretti S,et al.Thymosin alfa 1 administration improves immune reconstitution and decreases infection-related mortality after HLA-matched sibling T cell-depleted stem cell transplantation.2011 ASH Meeting:Abstract 1013.
  • [12]Synons HJ, Kesserwan C, Kos F, et al. Favorable immune reconstitution after nonmyeloablative, T-cell replete, HLA-haploidentical BMT with post-transplant cyclophosphamide. 2011 ASH Meeting:Abstract 1009.
  • [13]Dominietto A, Raiola AM, Bruno B, et al. Rapid immune reconstitution following unmanipulated haploidentical BMT with posttransplant high dose cyclophosphamide.2011 ASH Meeting:Abstract 3050.
  • [14]Ciurea SO,Saliba RM,Bayraktar UD,et al.Improved early outcomes with T-cell replete (TCR) compared with T-cell depleted (TCD)haploidentical stem cell transplantation (HaploSCT). 2011 ASH Meeting:Abstract 320.
  • [15]Bao L,Cowan MJ,Dunham K,et al.Adoptive inmunotherapy with CMV specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections.2011 ASH Meeting:Abstract 4033.
  • [16]Hanley PJ,Martinez C,Leung K,et al.Phase I study to improve virusspecific immune reconstitution after cord blood transplantation using cord blood-derived virus-specific cytotoxic T lymphocytes.2011 ASH Meeting:Abstract 155.
  • [17]Borchers S,Stadler M,Luthe S,et al.Persistence of recipient-derived antiviral T cells severely influence donor chimerism post allogeneic HSCT.2011 ASH Meeting:Abstract 3240.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615